Alleviant ALLAY-HFrEF Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gregg Stone
Icahn School of Medicine at Mount Sinai
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
61 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Monash Health Victorian Heart Hospital
Clayton, Victoria, Australia
- Alfred Hospital
Melbourne, Victoria, Australia
- Olv Hospital
Aalst, Belgium
- Zas Middelheim
Antwerp, Belgium
- Az Sint Jan Brugge
Bruges, Belgium
- Southlake Regional Hospital Centre
Newmarket, Ontario, Canada
- Centre Integre Universitaire de Sainte Et de Services Scoiiaux de L'Estrie - Centre Hospitalier Universitaire de Sherbrooke (ciusss de L'Estrie - Chus)
Montreal, Quebec, Canada
- Centre Hospitalier de L'Universite de Montreal (chum)
Montreal, Quebec, Canada
- Iucpq - Université Laval (quebec)
Québec, Canada
- Tbilisi Heart and Vascular
Tbilisi, Georgia
- Hygeia Hospital
Athens, Greece
- European Interbalken Medical Center
Thessaloniki, Greece
- Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
- Shamir Medical Center
Zrifin, Israel
- Christchurch Hospital
Christchurch, New Zealand
- Dunedin Hospital
Dunedin, New Zealand
- University Clinical Hospital in Opole
Opole, Poland
- Narodowy Instytut Kardiologii Im. Stefana Kardynała Wyszyńsk
Warsaw, Poland
- Uniwesytecki Szpital Kliniczny
Wroclaw, Poland
- Hospital Universitario A Coruna
A Coruña, Spain
- Hospital de la Santa Creu I Sant Pau
Barcelona, Spain
- Vall D'Hebron University Hospital Barcelona
Barcelona, Spain
- Hospital Universitario 12 de Octubre
Madrid, Spain
- Hospital Universitario Puerta de Hierro
Madrid, Spain
- Hospital Clínico Universitario de Salamanca
Salamanca, Spain
- Valencia Hospital Clinico
Valencia, Spain
- Keck Medical Center of Usc
Los Angeles, California, United States
- Uc Davis Medical Center
Sacramento, California, United States
- Scripps Clinical Research Services
San Diego, California, United States
- University of California San Francisco
San Francisco, California, United States
- Delray Medical Center
Delray Beach, Florida, United States
- Ascension Sacred Heart
Pensacola, Florida, United States
- Tampa General Hospital
Tampa, Florida, United States
- Atlanta Va Health Care System
Decatur, Georgia, United States
- Midwest Cardiovascular Institute
Naperville, Illinois, United States
- Cardiovascular Institute of the South
Houma, Louisiana, United States
- University Medical Center New Orleans
New Orleans, Louisiana, United States
- Boston Medical Center
Boston, Massachusetts, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Tufts Medical Center
Boston, Massachusetts, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Mar 2025
- Primary completion
- 31 Dec 2028
- Completion
- 31 Dec 2028
- Last update posted
- 3 Jun 2026
- Registered enrollment
- 350
- Registry id
- NCT06812533
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.